Abstract
RECENTLY, long-lasting hypotensive agents have been described which act by blocking adrenergic neurones: of these, guanethidine1 and bretylium2 have been widely used clinically.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Boura, A. L. A., and Green, A. F., Brit. J. Pharmacol., 14, 536 (1959).
Maxwell, R. A., Plummer, A. J., Schneider, F., Povalski, H., and Daniel, A. I., J. Pharmacol. Exp. Therap., 128, 22 (1960).
Gyermek, L., and Nádor, K., Pharmazie, 10, 485 (1955).
Dóda, M., and György, L. (unpublished data).
For nomenclature, see Fodor, G., and Nádor, K., J. Chem. Soc., 721 (1953).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
DÓDA, M., GYÖRGY, L. & NÁDOR, K. Adrenergic Neurone Blocking Tropine Derivatives with Long-lasting Hypotensive Action. Nature 195, 1108–1109 (1962). https://doi.org/10.1038/1951108a0
Issue date:
DOI: https://doi.org/10.1038/1951108a0
